Predictors of two months culture conversion in multidrug-resistant tuberculosis: findings from a retrospective cohort study
- PMID: 24705411
- PMCID: PMC3976287
- DOI: 10.1371/journal.pone.0093206
Predictors of two months culture conversion in multidrug-resistant tuberculosis: findings from a retrospective cohort study
Abstract
Background: Various studies have reported culture conversion at two months as a predictor of successful treatment outcome in multidrug-resistant tuberculosis (MDR-TB).
Objectives: The present study was conducted with the aim to evaluate the rate and predictors of culture conversion at two months in MDR-TB patients.
Methods: All confirmed pulmonary MDR-TB patients enrolled for treatment at Lady Reading Hospital Peshawar, Pakistan from 1 January to 31 December 2012 and met the inclusion criteria were reviewed retrospectively. Rate and predictors of culture conversion at two months were evaluated.
Results: Eighty seven (53.4%) out of 163 patients achieved culture conversion at two months. In a multivariate analysis lung cavitation at baseline chest X-ray (P = 0.006, OR = 0.349), resistance to ofloxacin (P = 0.041, OR = 0.193) and streptomycin (P = 0.017, OR = 0.295) had statistically significant (P<0.05) negative association with culture conversion at two months.
Conclusion: A reasonable proportion of patients achieved culture conversion at two months. Factors negatively associated with culture conversion at two months can be easily identified either before diagnosis or early in the course of MDR-TB treatment. This may help in better care of individual patients by identifying them early and treating them vigorously.
Conflict of interest statement
Similar articles
-
Predictors of delayed culture conversion in patients treated for multidrug-resistant tuberculosis in Pakistan.Int J Tuberc Lung Dis. 2011 Nov;15(11):1556-9, i. doi: 10.5588/ijtld.10.0679. Int J Tuberc Lung Dis. 2011. PMID: 22008773 Free PMC article.
-
Characteristics and treatment outcomes of patients with multi-drug resistant tuberculosis at a tertiary care hospital in Peshawar, Pakistan.Saudi Med J. 2015 Dec;36(12):1463-71. doi: 10.15537/smj.2015.12.12155. Saudi Med J. 2015. PMID: 26620989 Free PMC article.
-
Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome.Ann Intern Med. 2006 May 2;144(9):650-9. doi: 10.7326/0003-4819-144-9-200605020-00008. Ann Intern Med. 2006. PMID: 16670134
-
Outcomes of patients with multidrug-resistant pulmonary tuberculosis treated with ofloxacin/levofloxacin-containing regimens.Chest. 2000 Mar;117(3):744-51. doi: 10.1378/chest.117.3.744. Chest. 2000. PMID: 10713001
-
Delamanid: From discovery to its use for pulmonary multidrug-resistant tuberculosis (MDR-TB).Tuberculosis (Edinb). 2018 Jul;111:20-30. doi: 10.1016/j.tube.2018.04.008. Epub 2018 May 3. Tuberculosis (Edinb). 2018. PMID: 30029909 Review.
Cited by
-
Liaison of Sugar Control With Time to Sputum Culture Conversion in Multi-Drug Resistant Tuberculosis.Cureus. 2020 Jul 26;12(7):e9395. doi: 10.7759/cureus.9395. Cureus. 2020. PMID: 32864226 Free PMC article.
-
Malnutrition is Associated with Delayed Sputum Culture Conversion Among Patients Treated for MDR-TB.Infect Drug Resist. 2021 Apr 28;14:1659-1667. doi: 10.2147/IDR.S293461. eCollection 2021. Infect Drug Resist. 2021. PMID: 33953577 Free PMC article.
-
Time to sputum culture conversion and its determinants among Multi-drug resistant Tuberculosis patients at public hospitals of the Amhara Regional State: A multicenter retrospective follow up study.PLoS One. 2018 Jun 21;13(6):e0199320. doi: 10.1371/journal.pone.0199320. eCollection 2018. PLoS One. 2018. PMID: 29927980 Free PMC article.
-
Time to sputum smear and culture conversions in multidrug resistant tuberculosis at University of Gondar Hospital, Northwest Ethiopia.PLoS One. 2018 Jun 26;13(6):e0198080. doi: 10.1371/journal.pone.0198080. eCollection 2018. PLoS One. 2018. PMID: 29944658 Free PMC article.
-
Sputum culture conversion and its predictors among drug-resistant pulmonary tuberculosis patients in eastern Ethiopia.Int Health. 2025 May 1;17(3):292-303. doi: 10.1093/inthealth/ihae059. Int Health. 2025. PMID: 39348935 Free PMC article.
References
-
- Chan ED, Laurel V, Strand MJ, Chan JF, Huynh MLN, et al. (2004) Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis. Am J Respir Crit Care Med 169: 1103–1109. - PubMed
-
- Behr M, Warren S, Salamon H, Hopewell P, Ponce dLA, et al. (1999) Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet 353: 444–9. - PubMed
-
- Diacon AH, Pym A, Grobusch M, Patientia R, Rustomjee R, et al. (2009) The diarylquinoline TMC207 for multidrug-resistant tuberculosis. N Engl J Med 360: 2397–405. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous